{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T09:22:04Z","timestamp":1791537724584,"version":"4.3.4"},"reference-count":44,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institute of Health","doi-asserted-by":"publisher","award":["GM115305-01"],"award-info":[{"award-number":["GM115305-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institute of Health","doi-asserted-by":"publisher","award":["AI110527-01A1"],"award-info":[{"award-number":["AI110527-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institute of Health","doi-asserted-by":"publisher","award":["AI139021"],"award-info":[{"award-number":["AI139021"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institute of Health","doi-asserted-by":"publisher","award":["AI136815"],"award-info":[{"award-number":["AI136815"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"MRC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"NIHR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["1K43TW011178-01"],"award-info":[{"award-number":["1K43TW011178-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.jaci.2018.10.030","type":"journal-article","created":{"date-parts":[[2018,12,17]],"date-time":"2018-12-17T08:06:29Z","timestamp":1545033989000},"page":"66-73","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":186,"title":["Controversies in drug allergy: Testing for delayed reactions"],"prefix":"10.1016","volume":"143","author":[{"given":"Elizabeth J.","family":"Phillips","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Bigliardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas J.","family":"Bircher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Broyles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoon-Seok","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Hung","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rannakoe","family":"Lehloenya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Mockenhaupt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonny","family":"Peter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munir","family":"Pirmohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Claude","family":"Roujeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil H.","family":"Shear","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana Kase","family":"Tanno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Trubiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocco","family":"Valluzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annick","family":"Barbaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2018.10.030_bib1","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jaip.2017.01.025","article-title":"Severe delayed cutaneous and systemic reactions to drugs: a global perspective on the science and art of current practice","volume":"5","author":"Peter","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2018.10.030_bib2","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jaci.2015.05.050","article-title":"Evolving models of the immunopathogenesis of T cell-mediated drug allergy: the role of host, pathogens, and drug response","volume":"136","author":"White","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.10.030_bib3","doi-asserted-by":"crossref","first-page":"9959","DOI":"10.1073\/pnas.1207934109","article-title":"Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire","volume":"109","author":"Ostrov","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2018.10.030_bib4","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/nature11147","article-title":"Immune self-reactivity triggered by drug-modified HLA-peptide repertoire","volume":"486","author":"Illing","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2018.10.030_bib5","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.iac.2017.07.007","article-title":"Severe delayed drug reactions: role of genetics and viral infections","volume":"37","author":"Pavlos","year":"2017","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaci.2018.10.030_bib6","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1111\/bcp.13294","article-title":"Pharmacogenomics of off-target adverse drug reactions","volume":"83","author":"Garon","year":"2017","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jaci.2018.10.030_bib7","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1056\/NEJMoa0706135","article-title":"HLA-B*5701 screening for hypersensitivity to abacavir","volume":"358","author":"Mallal","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2018.10.030_bib8","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1086\/529382","article-title":"High sensitivity of human leukocyte antigen-b*5701 as a marker for immunologically confirmed abacavir hypersensitivity in white and black patients","volume":"46","author":"Saag","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaci.2018.10.030_bib9","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jaip.2017.11.023","article-title":"SJS\/TEN 2017: building multidisciplinary networks to drive science and translation","volume":"6","author":"White","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2018.10.030_bib10","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1136\/annrheumdis-2013-203893","article-title":"Significant associations of antidrug antibody levels with serum drug trough levels and therapeutic response of adalimumab and etanercept treatment in rheumatoid arthritis","volume":"74","author":"Chen","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaci.2018.10.030_bib11","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/428486a","article-title":"Medical genetics: a marker for Stevens-Johnson syndrome","volume":"428","author":"Chung","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2018.10.030_bib12","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1056\/NEJMoa1213096","article-title":"HLA-B*13:01 and the dapsone hypersensitivity syndrome","volume":"369","author":"Zhang","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2018.10.030_bib13","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/ng.379","article-title":"HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin","volume":"41","author":"Daly","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaci.2018.10.030_bib14","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/cpt.1004","article-title":"Clinical Pharmacogenetics Implementation Consortium Guideline for HLA genotype and use of carbamazepine and oxcarbazepine: 2017 update","volume":"103","author":"Phillips","year":"2018","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jaci.2018.10.030_bib15","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1056\/NEJMoa1013297","article-title":"HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans","volume":"364","author":"McCormack","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2018.10.030_bib16","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1001\/jamaneurol.2018.0278","article-title":"Association of HLA-A*31:01 screening with the incidence of carbamazepine-induced cutaneous adverse reactions in a Japanese population","volume":"75","author":"Mushiroda","year":"2018","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.jaci.2018.10.030_bib17","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.4049\/jimmunol.1700851","article-title":"Cytomegalovirus (CMV) epitope-specific CD4(+) T cells are inflated in HIV(+) CMV(+) subjects","volume":"199","author":"Abana","year":"2017","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2018.10.030_bib18","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/bjd.12125","article-title":"A multicentre study to determine the value and safety of drug patch tests for the three main classes of severe cutaneous adverse drug reactions","volume":"168","author":"Barbaud","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2018.10.030_bib19","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.iac.2009.04.010","article-title":"Skin testing in delayed reactions to drugs","volume":"29","author":"Barbaud","year":"2009","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaci.2018.10.030_bib20","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1097\/00002030-200211080-00017","article-title":"Utility of patch testing in patients with hypersensitivity syndromes associated with abacavir","volume":"16","author":"Phillips","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.jaci.2018.10.030_bib21","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0091-6749(03)01783-4","article-title":"Nonirritating intradermal skin test concentrations for commonly prescribed antibiotics","volume":"112","author":"Empedrad","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.10.030_bib22","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/all.12142","article-title":"Skin test concentrations for systemically administered drugs\u2014an ENDA\/EAACI Drug Allergy Interest Group position paper","volume":"68","author":"Brockow","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2018.10.030_bib23","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature14022","article-title":"Identification of a mast-cell-specific receptor crucial for pseudo-allergic drug reactions","volume":"519","author":"McNeil","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2018.10.030_bib24","article-title":"Brief communication: MRGPRX2, atopic dermatitis and red man syndrome","volume":"2","author":"Azimi","year":"2017","journal-title":"Itch (Phila)"},{"key":"10.1016\/j.jaci.2018.10.030_bib25","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jaip.2017.08.003","article-title":"A survey of drug allergy training opportunities in the United States","volume":"6","author":"Derrick","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2018.10.030_bib26","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.jaip.2017.09.004","article-title":"The combined utility of ex\u00a0vivo IFN-gamma release enzyme-linked immunospot assay and in\u00a0vivo skin testing in patients with antibiotic-associated severe cutaneous adverse reactions","volume":"6","author":"Trubiano","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2018.10.030_bib27","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1468-3083.2011.04418.x","article-title":"A patch testing and cross-sensitivity study of carbamazepine-induced severe cutaneous adverse drug reactions","volume":"27","author":"Lin","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaci.2018.10.030_bib28","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1034\/j.1398-9995.2001.056008790.x","article-title":"Cephalexin tolerated despite delayed aminopenicillin reactions","volume":"56","author":"Phillips","year":"2001","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2018.10.030_bib29","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1034\/j.1600-0536.2001.450601.x","article-title":"Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse drug reactions","volume":"45","author":"Barbaud","year":"2001","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.jaci.2018.10.030_bib30","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1046\/j.0105-4538.2001.00001.x-i8","article-title":"General considerations for skin test procedures in the diagnosis of drug hypersensitivity","volume":"57","author":"Brockow","year":"2002","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2018.10.030_bib31","first-page":"9","article-title":"The drug ambassador project\u2014the diversity of diagnostic procedures for drug allergy around Europe","volume":"17","author":"Gomes","year":"2005","journal-title":"Allergy Clin Immunol Int"},{"key":"10.1016\/j.jaci.2018.10.030_bib32","article-title":"The safety of antibiotic skin testing in severe T-cell-mediated hypersensitivity of immunocompetent and immunocompromised hosts","author":"Trubiano","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2018.10.030_bib33","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s11882-014-0442-8","article-title":"Skin testing and patch testing in non-IgE-mediated drug allergy","volume":"14","author":"Barbaud","year":"2014","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jaci.2018.10.030_bib34","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/cod.12842","article-title":"Patch testing in non-immediate cutaneous adverse drug reactions: value of extemporaneous patch tests","volume":"77","author":"Assier","year":"2017","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.jaci.2018.10.030_bib35","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/cod.12269","article-title":"Non-irritant concentrations and amounts of active ingredient in drug patch tests","volume":"71","author":"Brajon","year":"2014","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.jaci.2018.10.030_bib36","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jaci.2018.09.022","article-title":"Controversies in drug allergy: in\u00a0vitro testing","volume":"143","author":"Mayorga","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.10.030_bib37","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1111\/all.12886","article-title":"In\u00a0vitro tests for drug hypersensitivity reactions: an ENDA\/EAACI Drug Allergy Interest Group position paper","volume":"71","author":"Mayorga","year":"2016","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2018.10.030_bib38","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.anai.2010.08.002","article-title":"Drug allergy: an updated practice parameter","volume":"105","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2018.10.030_bib39","doi-asserted-by":"crossref","first-page":"e160033","DOI":"10.1001\/jamapediatrics.2016.0033","article-title":"Assessing the diagnostic properties of a graded oral provocation challenge for the diagnosis of immediate and nonimmediate reactions to amoxicillin in children","volume":"170","author":"Mill","year":"2016","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.jaci.2018.10.030_bib40","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1080\/00015550510042859","article-title":"Oral challenge in patients with suspected cutaneous adverse drug reactions: findings in 784 patients during a 25-year-period","volume":"85","author":"Lammintausta","year":"2005","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaci.2018.10.030_bib41","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1111\/j.1398-9995.2011.02554.x","article-title":"Drug re-challenges in cutaneous adverse drug reactions: information and effectiveness in the long-term management of patients","volume":"66","author":"Waton","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2018.10.030_bib42","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1398-9995.2009.02228.x","article-title":"Determining the negative predictive value of provocation tests with beta-lactams","volume":"65","author":"Demoly","year":"2010","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2018.10.030_bib43","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/j.jaip.2017.10.008","article-title":"Natural history of benign nonimmediate allergy to beta-lactams in children: a prospective study in retreated patients after a positive and a negative provocation test","volume":"6","author":"Tonson la Tour","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2018.10.030_bib44","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/j.jaip.2017.03.032","article-title":"\u201cTreating through\u201d decision and follow-up in antibiotic therapy-associated exanthemas","volume":"5","author":"Trautmann","year":"2017","journal-title":"J Allergy Clin Immunol Pract"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674918315690?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674918315690?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:19:34Z","timestamp":1758791974000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674918315690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S0091674918315690"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2018.10.030","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.734676752.793558771","asserted-by":"object"}]},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Controversies in drug allergy: Testing for delayed reactions","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2018.10.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}